|
BBS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.479400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.503400E-01 |
| Normal-vs-Stage2 |
5.629400E-01 |
| Normal-vs-Stage3 |
1.302980E-01 |
| Normal-vs-Stage4 |
2.389300E-04 |
| Stage1-vs-Stage2 |
7.822600E-01 |
| Stage1-vs-Stage3 |
2.101200E-01 |
| Stage1-vs-Stage4 |
6.860200E-02 |
| Stage2-vs-Stage3 |
5.095600E-01 |
| Stage2-vs-Stage4 |
1.290810E-01 |
| Stage3-vs-Stage4 |
2.611000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.302400E-01 |
| Normal-vs-AfricanAmerican |
4.373500E-02 |
| Normal-vs-Asian |
2.087800E-01 |
| Caucasian-vs-AfricanAmerican |
8.335900E-02 |
| Caucasian-vs-Asian |
3.032600E-01 |
| AfricanAmerican-vs-Asian |
5.197600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.997400E-01 |
| Normal-vs-Female |
4.855000E-01 |
| Male-vs-Female |
9.085000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.600000E-04 |
| Normal-vs-Extreme_Weight |
3.377800E-01 |
| Normal-vs-Obese |
5.914000E-01 |
| Normal-vs-Extreme_Obese |
9.603400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.593700E-02 |
| Normal_Weight-vs-Obese |
2.754000E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.754800E-01 |
| Extreme_Weight-vs-Obese |
7.600000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.658200E-01 |
| Obese-vs-Extreme_Obese |
7.753200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.602230E-01 |
| Normal-vs-Age(41-60Yrs) |
8.461600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.646000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.164100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.365000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.712600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.094200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.489000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.231600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.691900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.956800E-01 |
| Normal-VS-Type2 PRCC |
9.160900E-03 |
| Normal-VS-KIRP CIMP |
1.548800E-01 |
| Normal-VS-Unclassified PRCC |
5.299200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.015300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.898750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.740800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.676000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.493600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.180800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.301800E-03 |
| Normal-vs-N1 |
2.691600E-02 |
| Normal-vs-N2 |
2.567900E-04 |
| N0-vs-N1 |
8.328000E-01 |
| N0-vs-N2 |
2.777800E-01 |
| N1-vs-N2 |
1.322980E-01 |
|
|
